Leveljump HealthcareJMPHF Altman Z-Score is 0.04 as of Jun. 30, 2026. The stock has 2 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, Leveljump Healthcare ranks worse than 73.27% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Warning Sign:
Altman Z-score of 0.06 is in distress zone. This implies bankruptcy possibility in the next two years.
Leveljump Healthcare has a Altman Z-Score of 0.04, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Leveljump Healthcare's Altman Z-Score or its related term are showing as below:
JMPHF'
s Altman Z-Score Range Over the Past 10 Years
Min: -7.87 Med: -0.5 Max: 0.63
Current: 0.06
During the past 6 years, Leveljump Healthcare's highest Altman Z-Score was 0.63. The lowest was -7.87. And the median was -0.50.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Leveljump Healthcare Altman Z-Score Related Terms
Leveljump Healthcare Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Leveljump Healthcare's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMPHF vs TMO, DHR, IDXX: Altman Z-Score Comparison
For the Diagnostics & Research subindustry, Leveljump Healthcare's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leveljump Healthcare Altman Z-Score vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Leveljump Healthcare's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Leveljump Healthcare's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Leveljump Healthcare's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
-0.1204
+
1.4
*
-0.7108
+
3.3
*
0.039
+
0.6
*
0.3339
+
1.0
*
0.8547
=
0.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Leveljump Healthcare (JMPHF) has a Altman Z-Score of 0.04 as of Jun. 30, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Leveljump Healthcare and its competitors. According to the industry distribution chart, Leveljump Healthcare ranks #148 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 73.3%.
Is Leveljump Healthcare's Altman Z-Score too high?
Leveljump Healthcare's current Altman Z-Score is 0.04. The Medical Diagnostics & Research industry median Altman Z-Score is 2.39. Leveljump Healthcare's value of 0.04 is 98.3% below this industry median. Based on the distribution chart, Leveljump Healthcare ranks #148 out of 202 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint.
How does Leveljump Healthcare's Altman Z-Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Leveljump Healthcare ranks #148 out of 202 companies for Altman Z-Score. This places Leveljump Healthcare in the lower half of its industry. The industry median Altman Z-Score is 2.39. Leveljump Healthcare's value of 0.04 is 98.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Diagnostics & Research company?
The median Altman Z-Score among Medical Diagnostics & Research companies is 2.39, based on 202 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leveljump Healthcare's current Altman Z-Score of 0.04 is 98.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Leveljump Healthcare and its competitors. For the Medical Diagnostics & Research industry, the median Altman Z-Score is 2.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leveljump Healthcare's current Altman Z-Score is 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leveljump Healthcare stock overvalued right now?
Leveljump Healthcare (JMPHF) has a current Altman Z-Score of 0.04. The stock's GF Value™ is $0.05, compared to a current price of $0.04 — trading 14.5% below its estimated fair value. The current Altman Z-Score is 0.04 and 98.3% below the Medical Diagnostics & Research industry median of 2.39. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Leveljump Healthcare (JMPHF), the current Altman Z-Score is 0.04 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Leveljump Healthcare Corp is engaged in providing radiology services both by providing direct patient images and by providing Teleradiology services, which is the process of providing remote off-site reading of radiology scans such as CT, MRI, and X-ray. Its teleradiology services allow hospital staff to scan their emergency room patients, then page the company's radiologist on call, who can then remotely view, via a secured server, the images and diagnose the patient, and provide a report back to the hospital. Leveljump provides its direct-to-patient services at its Independent Healthcare Facilities (IHFs). The company operates as a single segment, with all of its core assets, intellectual property, and development work being conducted in Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JMPHF has been successfully added to your 